PUBLISHER: Grand View Research | PRODUCT CODE: 1493369
PUBLISHER: Grand View Research | PRODUCT CODE: 1493369
The U.S. cardiology procedures market size is expected to reach USD 92.32 billion by 2030, expanding at a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of cardiovascular diseases (CVDs) among the population is driven by factors such as sedentary lifestyles, poor dietary habits, and an aging population. As CVDs remain a leading cause of mortality in the U.S., there's a heightened focus on early detection, diagnosis, and treatment, leading to a surge in demand for cardiology procedures.According to the Heart and Stroke Statistics 2022 by the American Heart Association, more than 356,000 out-of-hospital cardiac arrests occur in the U.S. every year, with around 90% of them resulting in death.
According to the WHO, the global population aged 60 and above is expected to increase significantly from around 1 billion in 2020 to about 1.4 billion in 2030 and almost double to around 2.1 billion by 2050. The number of elderly patients suffering from critical illnesses has significantly increased in recent years. The rising number of elderly patients suffering from critical illnesses has led to a surge in the utilization of cardiology procedures such as coronary angioplasty, stenting, cardiac ablation, and implantable device placement. These procedures are essential for diagnosing, treating, and managing various cardiovascular conditions, helping to improve patient outcomes and quality of life. Furthermore, the aging population is often associated with a higher burden of comorbidities and complex medical needs, which may necessitate more frequent and intensive cardiac interventions.